Alector, Inc. (NASDAQ:ALEC) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Alector Second Quarter and Midyear 2024 Earnings Conference Call. At this time, all participants are in listen-only mode.
Alector Inc. (ALEC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 9,695,228 | $18,323,981 | 0.24% | |
| 2. | Euclidean Capital Jim Simons | 1,307,858 | $2,471,852 | 0.33% | |
| 3. | Deerfield Management James E. Flynn | 1,066,962 | $2,016,558 | +2% | 0.03% |
| 4. | Ikarian Capital Neil Shahrestani | 950,000 | $1,795,501 | 0.24% | |
| 5. | Renaissance Technologies Jim Simons | 915,738 | $1,730,745 | +64% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.00 | 20,000 | Director | 44,621 | 2020-02-03 | Filing | |
| $19.00 | 203,200 | Large Shareholder, Director | 203,200 | 2019-02-11 | Filing | |
| $19.00 | 50,561 | Large Shareholder, Director | 2,455,853 | 2019-02-11 | Filing | |
| $19.00 | 157,939 | Large Shareholder, Director | 10,434,976 | 2019-02-11 | Filing | |
| $19.00 | 203,200 | Large Shareholder, Director | 203,200 | 2019-02-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.52 | 16,489 | 330,651 | 2024-12-02 | Filing | ||
| $2.52 | 52,172 | 2,507,074 | 2024-12-02 | Filing | ||
| $2.52 | 26,500 | 565,215 | 2024-12-02 | Filing | ||
| $2.52 | 14,892 | 349,283 | 2024-12-02 | Filing | ||
| $4.88 | 7,297 | 130,740 | 2024-09-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,689,865 | $27,763,845 | 0% | |
| 2. | 9,136,747 | $17,268,452 | 0% | |
| 3. | 5,616,379 | $10,614,955 | 0% | |
| 4. | 3,545,719 | $6,701,409 | 2.59% | |
| 5. | 1,914,250 | $3,618,908 | 0% |
News See All
10 Best Biotech Penny Stocks to Buy Now
In 2024, the healthcare industry has been doing well, encouraging investors to look into new and exciting opportunities.
Alector, Inc. (NASDAQ:ALEC) Q4 2023 Earnings Call Transcript
Alector, Inc. beats earnings expectations. Reported EPS is $-0.49, expectations were $-0.8. Alector, Inc.
Alector, Inc. (NASDAQ:ALEC) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Alector Midyear 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
5 Best Biotech and AI Stocks To Buy According To Billionaire Jim Simons
In this article, we discuss 5 stock picks of Jim Simons’ Euclidean Capital.
10 Pharmaceutical Stocks to Buy According to Jim Simons’ Euclidean Capital
In this article, we reviewed Jim Simons' investment strategy, historical performance, and family office portfolio.
5 Best Pharma and Biotech Stocks to Buy According to Jim Simons' Euclidean Capital
In this article, we discuss the 5 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital.
Is Alector (ALEC) a Smart Long-term Buy?
Baron Health Care Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
25 Easiest Trivia Questions For Seniors With Dementia
Dementia is a terrible disease, but these 25 easiest trivia questions for seniors with dementia will perhaps provide a bright spark in the day for anyone afflicted with the illness.
Hedge Funds Are Piling Into Alector, Inc. (ALEC)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Billionaire Hedge Funds
